These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32599081)

  • 1. Functional loss of pancreatic islets in type 2 diabetes: How can we halt it?
    Marrano N; Biondi G; Cignarelli A; Perrini S; Laviola L; Giorgino F; Natalicchio A
    Metabolism; 2020 Sep; 110():154304. PubMed ID: 32599081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MC1568 improves insulin secretion in islets from type 2 diabetes patients and rescues β-cell dysfunction caused by Hdac7 upregulation.
    Daneshpajooh M; Eliasson L; Bacos K; Ling C
    Acta Diabetol; 2018 Dec; 55(12):1231-1235. PubMed ID: 30088095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes.
    Donath MY; Gross DJ; Cerasi E; Kaiser N
    Diabetes; 1999 Apr; 48(4):738-44. PubMed ID: 10102689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.
    Marchetti P; Del Guerra S; Marselli L; Lupi R; Masini M; Pollera M; Bugliani M; Boggi U; Vistoli F; Mosca F; Del Prato S
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5535-41. PubMed ID: 15531508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment.
    Marchetti P; Dotta F; Lauro D; Purrello F
    Regul Pept; 2008 Feb; 146(1-3):4-11. PubMed ID: 17889380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction.
    Hansson SF; Zhou AX; Vachet P; Eriksson JW; Pereira MJ; Skrtic S; Jongsma Wallin H; Ericsson-Dahlstrand A; Karlsson D; Ahnmark A; Sörhede Winzell M; Magnone MC; Davidsson P
    PLoS One; 2018; 13(4):e0196601. PubMed ID: 29702679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Genome Bisulfite Sequencing of Human Pancreatic Islets Reveals Novel Differentially Methylated Regions in Type 2 Diabetes Pathogenesis.
    Volkov P; Bacos K; Ofori JK; Esguerra JL; Eliasson L; Rönn T; Ling C
    Diabetes; 2017 Apr; 66(4):1074-1085. PubMed ID: 28052964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.
    Kakimoto T; Kimata H; Iwasaki S; Fukunari A; Utsumi H
    J Endocrinol; 2013 Jan; 216(1):13-20. PubMed ID: 23092878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of incretin therapy on islet dysfunction: an underlying defect in the pathophysiology of type 2 diabetes.
    McGill JB
    Postgrad Med; 2009 Jan; 121(1):46-58. PubMed ID: 19179813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity.
    Kaneto H; Kajimoto Y; Miyagawa J; Matsuoka T; Fujitani Y; Umayahara Y; Hanafusa T; Matsuzawa Y; Yamasaki Y; Hori M
    Diabetes; 1999 Dec; 48(12):2398-406. PubMed ID: 10580429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Carlbom L; Espes D; Lubberink M; Martinell M; Johansson L; Ahlström H; Carlsson PO; Korsgren O; Eriksson O
    Diabetes; 2017 May; 66(5):1286-1292. PubMed ID: 28246291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
    Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
    Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.
    Lupi R; Del Prato S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S56-64. PubMed ID: 18640587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
    Mu J; Woods J; Zhou YP; Roy RS; Li Z; Zycband E; Feng Y; Zhu L; Li C; Howard AD; Moller DE; Thornberry NA; Zhang BB
    Diabetes; 2006 Jun; 55(6):1695-704. PubMed ID: 16731832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic stellate cells in the islets as a novel target to preserve the pancreatic β-cell mass and function.
    Yang Y; Kim JW; Park HS; Lee EY; Yoon KH
    J Diabetes Investig; 2020 Mar; 11(2):268-280. PubMed ID: 31872946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet β cell mass in diabetes and how it relates to function, birth, and death.
    Weir GC; Bonner-Weir S
    Ann N Y Acad Sci; 2013 Apr; 1281(1):92-105. PubMed ID: 23363033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathophysiological basis for intensive insulin replacement.
    Rolla A
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S3-7. PubMed ID: 15306831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.